Evaluation of clindamycin use in bone and joint infections: is monotherapy a safe option? A monocentric observational study 2014–19
Clindamycin monotherapy appears to be a reliable and safe therapeutic option for selected patients with less severe BJI.
Authors
- Denis Mulleman (ORCID: https://orcid.org/0000-0003-4089-7513)
- Simon Jamard (ORCID: https://orcid.org/0000-0001-9664-7340)
- Adrien Lemaignen (ORCID: https://orcid.org/0000-0001-5974-5689)
- Louis‐Romée Le Nail (ORCID: https://orcid.org/0000-0003-1642-4935)
- Marion Lacasse (ORCID: https://orcid.org/0000-0001-7372-6361)
- Laura Chaufour
- Vianney Tuloup
- Geoffroy Dubois De Montmarin
Institutions
- Université de Tours (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Hôpital Bretonneau (FR)
- Thion Medical (France) (FR)
- Infectiologie et santé publique (FR)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1093/jacamr/dlaf164
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00